loadpatents
Patent applications and USPTO patent grants for CHIN; Chen-Ni.The latest application filed is for "b7h4-targeted antibody-drug conjugates and methods of use thereof".
Patent | Date |
---|---|
B7h4-targeted Antibody-drug Conjugates And Methods Of Use Thereof App 20220233707 - LOWINGER; Timothy B. ;   et al. | 2022-07-28 |
Chimeric Antigen Receptors Comprising Bcma-specific Fibronectin Type Iii Domains And Uses Thereof App 20220031822 - CHIN; Chen Ni ;   et al. | 2022-02-03 |
Chimeric antigen receptors comprising BCMA-specific fibronectin type III domains and uses thereof Grant 11,096,998 - Chin , et al. August 24, 2 | 2021-08-24 |
Chimeric Antigen Receptors Comprising BCMA-specific Fibronectin Type III Domains and Uses Thereof App 20190330361 - Chin; Chen Ni ;   et al. | 2019-10-31 |
Methods For Screening For Modulators Of Gdf15-like Biological Activity App 20190234935 - Armstrong; Anthony ;   et al. | 2019-08-01 |
Peptide compounds for treating obesity and insulin resistance App 20090104210 - Tota; Michael R. ;   et al. | 2009-04-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.